https://www.drugs.com/fda/gadolinium-based-contrast-agents-gbcas-safety-communication-retained-body-new-class-warnings-14094.html?utm_source=ddc&utm_medium=email&utm_campaign=FDA+Alert+-+Drug+Safety+Communication%3A+Gadolinium-based+Contrast+Agents+%28GBCAs%29+-+Retained+in+Body%3B+New+Class+Warnings
Gadolinium-based Contrast Agents (GBCAs): Drug Safety Communication - Retained in Body; New Class Warnings